acetazolamide has been researched along with Psychotic Disorders in 3 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Excerpt | Relevance | Reference |
---|---|---|
"Acetazolamide was given to 30 patients: Type I, puberal periodic psychosis, a psychosis whose onset occurs during the period of puberty and which appears repetitively with psychosis-like condition at about the same interval as the menstrual cycle (6 cases); Type II, a) presenile atypical psychosis which initially appears in patients in their 20s or 30s accompanied by manic-depressive cycles and shows acute confusional and dreamy states in the presenile period, incurable cases (7), b) atypical psychosis, in the narrow sense, cases which show acute hallucination, delusion, confusional and dreamy states accompanied by affective symptoms (8 cases); Type III, repetitively the atypical manic and depressive states, and atypical manic-depressive psychosis, and transient changes in consciousness, refractory cases (2); Type IV, atypical schizophrenia, which is considered to be schizophrenia but shows the abnormalities in electroencephalogram and emotional disorders (7 cases)." | 1.27 | Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis. ( Fukuma, E; Hamazoe, K; Hazama, H; Ichikawa, M; Inoue, H; Inoue, K; Omura, F; Umezawa, Y, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koch, HJ | 1 |
Sykora, A | 1 |
Hausn, P | 1 |
HOFF, H | 1 |
PATEISKY, K | 1 |
Inoue, H | 1 |
Hazama, H | 1 |
Hamazoe, K | 1 |
Ichikawa, M | 1 |
Omura, F | 1 |
Fukuma, E | 1 |
Inoue, K | 1 |
Umezawa, Y | 1 |
3 other studies available for acetazolamide and Psychotic Disorders
Article | Year |
---|---|
[Off-label use of acetazolamide in a patient with familial hemiplegic migraine and concomitant psychotic episodes].
Topics: Acetazolamide; Adult; Anticonvulsants; Carbonic Anhydrase Inhibitors; Comorbidity; Drug Costs; Drug | 2010 |
[Decompensation in psychoses in the aged and treatment with diamox].
Topics: Acetazolamide; Aged; Dementia; Heart Failure; Mental Disorders; Psychotic Disorders | 1958 |
Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis.
Topics: Acetazolamide; Adolescent; Adult; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; H | 1984 |